VAV1 guanine nucleotide exchange factor inhibitors (Novartis Institutes for BioMedical Research)

N/A

Report date: 2025/03/20 09:26:00
NME

Base Information

Drug NameVAV1 guanine nucleotide exchange factor inhibitors (Novartis Institutes for BioMedical Research)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene vav degraders
TargetsProto-oncogene vav
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A